Evaluation of Diagnostic Criteria for Creutzfeldt Jakob Disease

Clinicians know little about Creutzfeldt Jakob disease, and they are not proficient in the diagnostic criteria of Creutzfeldt Jakob disease, so it is easy to misdiagnose or delay the diagnosis. As a rare central nervous system disease, it is necessary, feasible and practical to evaluate the diagnostic criteria of Creutzfeldt Jakob disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Creutzfeldt Jakob Disease Brain Diseases Central Nervous System Diseases Central Nervous System Infections Creutzfeldt-Jakob Syndrome Dementia Infections Mental Disorders Nervous System Diseases Neurocognitive Disorders Prion Diseases

Sex eligibility

All sexes

Study type

Observational

About this study

To master the clinical application of the diagnosis of Creutzfeldt Jakob disease (WS / T 562-2017) and the problems in the implementation process; The rationality, practicability and operability of the diagnostic criteria were evaluated scientifically; Reduce the misdiagnosis rate; To provide clinical basis and suggestions for further improving the diagnostic criteria. Through consulting the literature of Creutzfeldt Jakob disease, the clinical manifestations, laboratory examination, auxiliary examination and pathological results of Creutzfeldt Jakob disease were analyzed and compared with the current diagnostic criteria; The clinical diagnosis and misdiagnosis of Creutzfeldt Jakob disease were analyzed; To train medical staff at all levels to apply the diagnostic criteria of Creutzfeldt Jakob disease, and to discuss the clinical cases of Creutzfeldt Jakob disease in many hospitals.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with Creutzfeldt Jakob disease

Exclusion criteria

none

Treatment and study plan

laboratory examination, auxiliary examination, pathological results

Diagnostic Test

Personal information (sex, age), medical history of present disease, past medical history, family history, symptoms and signs, supplementary examination items (including laboratory examination, impact examination)

Primary outcomes

Clinical manifestations

Time frame: 1 year

Clinical manifestations of patients

Sponsors and collaborators

Lead sponsor

Peking University Third Hospital

Other

Collaborators

Centers for Disease Control and Prevention, China

Registry information

Official study title

Follow up Evaluation of Diagnostic Criteria for Creutzfeldt Jakob Disease (WS / T 562-2017)

Important dates

Study start: 2000
Primary completion: 2020
Study completion: 2020
First posted: Jun 30, 2021
Registry last updated: Jun 30, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed